Jinoos Yazdany

Thrilled to share our new paper comparing different LLMs to extract TNFi reasons and treatment trajectories from UCSF de-identified EHR data with @bmeow19.bsky.social, A. Garcia-Agundez and @jyazdanymd.bsky.social published in JAMIA open.

academic.oup.com/jamiaopen/ar...

@ucsf-bchsi.bsky.social

Polypharmacy in Adults with Systemic Lupus Erythematosus. Graphical abstract created using BioRender

Cross-sectional study of adults with SLE in the US estimated 56.3% had polypharmacy (≥5 prescription or OTC meds).

Arthritis Care & Research
doi.org/10.1002/acr....

🎉 We're honored to present the Evelyn V. Hess Award to Dr. Karen Costenbader for advancing #lupus research and care, and the Mary Betty Stevens Prize to Dr. Andrea Fava for innovative research driving progress in lupus science.

Learn more about their research: buff.ly/cn8xViK

Friends today but not tomorrow - come to the #ACR25 Great Debate Monday at 8:30 am on #AI in #Rheumatology!!!

Hey #Rheumsky! We heard you’ve got a conference this weekend!

Wishing everyone in Chicago, IL this weekend for #ACR25 a wonderful conference experience!

The conference hashtag will send posts directly to the Rheumatology feed, so you won’t miss the action!

Listen to @sarahpollet.bsky.social & Julia Bongiorno explain how #UCSF’s IMPACC framework supports safe, equitable, and effective AI use on a new podcast. #AIinHealthcare @ucsfdocit.bsky.social

@sarahpollet.bsky.social @jyazdanymd.bsky.social @julia-adler-mils.bsky.social @saramurray.bsky.social

Thrilled to see my book on healthcare Al available for preorder! sites.prh.com/preview/6f5c...
I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks

Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market - Current Rheumatology Reports Purpose of review This update examines the current policy landscape for biosimilars, particularly those approved for treating rheumatoid arthritis. We review recent literature and recommend policies t...

If the U.S. government wants to save $$$, they should read our article on #biosimilars: link.springer.com/article/10.1...

ACR Journals on Air podcast banner

NEW Episode of the ACR Journals on Air podcast! 🎙️

Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations

🎧 Listen → acr.tw/4dE1lHe

Read the study → doi.org/10.1002/acr....

#Medsky

Miss the conversation on bias in healthcare AI?

🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly.

See how the experts broke it down: codex.ucsf.edu/events/codex...

@tradeoffs.org

Excellent career advice from Peter Hotez journals.plos.org/plosbiology/.... Also some good stuff here for universities to consider in the face of current challenges.

I’m excited to take on this new role and do my small smart to make sure AI is safe, fair, and effective. Best part is getting to work with visionary leaders like @julia-adler-mils.bsky.social @saramurray.bsky.social @sarahpollet.bsky.social and many others

🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-...

@jyazdanymd.bsky.social

Damage Control in the Wake of Political Action That Threatens the Integrity of Medical Research | Annals of Internal Medicine

www.acpjournals.org/doi/10.7326/...

I've been waiting for this one!!!

You made huge contributions @rheumcat.bsky.social! We were so lucky to have you work on the GRA❤️

Somewhere in the U.S., there’s a scientist staring at their NSF/NIH grant application wondering why they bother. This post is for you. Science and society both need you. Hang in there and know there is a whole community supporting you.

Fantastic, super clear explanation by Dr. Choo of NIH grants process: takes “tens of thousands of reviewers annually on more than 1000 meetings with study sections like the one I should have been sitting in Thursday.” Even if/when the freeze ends, can’t just be restarted with a snap.
🧪

Health Disparities are real & lethal. Research on ⬇️ health disparities & improving health among impacted pops is critical. The NIMHD (NIH Institute that focuses on ⬇️ disparities) website remains. But if you search NIH Health Disparities, the page is gone. Chilling.

Changes in DNA methylation are associated with systemic lupus erythematosus flare remission and clinical subtypes - Clinical Epigenetics Background Systemic lupus erythematosus (SLE) has numerous symptoms across organs and an unpredictable flare-remittance pattern. This has made it challenging to understand drivers of long-term SLE out...

Extremely pleased to see this published! It takes a whole division of rheumatology to be on the look out for active SLE patients in the clinics/hospital with an active flare to enroll them in research and follow them over time

clinicalepigeneticsjournal.biomedcentral.com/articles/10....

We have 2 fellowship positions available (1 pediatric rheumatology, 1 med-peds rheumatology) at the Children’s Hospital at Montefiore, Bronx, NY. We welcome #IMG and sponsor both J1 and H1b visas. You will never regret being part of this outstanding team! See information below if interested!

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://zsfgmedicine.ucsf.edu/sites/zsfgmedicine.ucsf.edu/files/2024-11/DOM%20Newsletter-November%202024%20%281%29.pdf

Dr. Jenny Mandal's Rheumatology Access Expansion (RAE: raeinitiative.org) has trained 111 primary care clinicians on Native American reservations around the U.S. to care for people with #RA. Read about her inspiring work at the link below. #rheumsky #UCSFrheum

Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus This randomized clinical trial investigates whether early application of mycophenolate mofetil improves long-term outcomes in patients with newly diagnosed systemic lupus erythematosus with a high tit...

This trial is very interesting - we need ways to prevent LN before it happens! Early MMF helps but for how long should rx continue? Also need to further define who will benefit. jamanetwork.com/journals/jam...

Good questions - it is interesting that we see the same patterns in UK study and in this US one. There is something going on (neither study designed to address causality). I think some detailed qualitative work would be a good next step.

Age, racial gaps in b/tsDMARD use for rheumatoid arthritis show ‘surprising’ stability WASHINGTON — Disparities in the use of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis, including among older, Black and Asian patients, have not c...

#ACR24 Older patients, those in low nSES areas, and certain racial/ethnic groups less likely to get b/tsDMARDs, trends that did not change over last decade.#RISE-registry. www.heal.com/news/rheumat...

For the second year, @ACRheum’s Global Engagement Committee along with @rheum_covid leaders were able to review over 60 applications and provide travel awards to these accomplished individuals to attend #ACR24

Phil Robinson tweeting at ACR staff Donna Hoyne in 2016 about the success of #ACR16

And I found this old tweet from @philipcrobinson from the first @ACRheum I attended in 2016, and it reminds me of why we do what we do, and what this program is about

@jyazdanymd.bsky.social
@profbeckyg.bsky.social
@nicoladalbeth.bsky.social